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ABSTRACT: In clinical practice, involuntary vocalizing
behaviors are typically associated with Tourette syndrome
and other tic disorders. However, they may also be en-
countered throughout the entire tenor of neuropsychiatry,
movement disorders, and neurodevelopmental syndromes.
Importantly, involuntary vocalizing behaviors may often con-
stitute a predominant clinical sign, and, therefore, their early
recognition and appropriate classification are necessary to
guide diagnosis and treatment. Clinical literature and video-
documented cases on the topic are surprisingly scarce. Here,
we pooled data from 5 expert centers of movement disor-
ders, with instructive video material to cover the entire range
of involuntary vocalizations in humans. Medical literature was
also reviewed to document the range of possible etiologies
associated with the different types of vocalizing behaviors
and to explore treatment options. We propose a phenomeno-
logical classification of involuntary vocalizations within differ-
ent categorical domains, including (1) tics and tic-like
vocalizations, (2) vocalizations as part of stereotypies,
(3) vocalizations as part of dystonia or chorea, (4) continuous
vocalizing behaviors such as groaning or grunting, (5) patho-
logical laughter and crying, (6) vocalizations resembling phys-
iological reflexes, and (7) other vocalizations, for example,
those associated with exaggerated startle responses, as part
of epilepsy and sleep-related phenomena. We provide com-
prehensive lists of their associated etiologies, including neu-
rodevelopmental, neurodegenerative, neuroimmunological,
and structural causes and clinical clues. We then expand on
the pathophysiology of the different vocalizing behaviors and
comment on available treatment options. Finally, we present
an algorithmic approach that covers the wide range of invol-
untary vocalizations in humans, with the ultimate goal of
improving diagnostic accuracy and guiding appropriate treat-
ment. © 2019 The Authors. Movement Disorders published
by Wiley Periodicals, Inc. on behalf of International Parkinson
and Movement Disorder Society.
Key Words: involuntary vocalizations; movement disor-
ders; vocalizing behavior
The ability to vocalize has only been a fairly recent
evolutionary acquisition and was a prerequisite for the
development of verbal communication in our species.1
Our acquired repertoire of vocalizations ranges from
simple sounds related to physiological reflexes (eg,
sneezing) and emotional responses (eg, crying,
laughing) to the intended articulation of words that are
meant to express specific communicative content.2 In
all these instances, vocalizations are typically context
specific and adaptive to environmental stimuli. How-
ever, the occurrence of vocalizing behaviors in the
absence of these qualities typically signifies pathology
and most often constitutes a major cause of distress.
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Medical literature and clinical practice have historically
associated abnormal vocalizing behaviors with tic disor-
ders, as for example, Tourette syndrome (TS), of which
they are also an essential part of the diagnostic criteria.3
However, involuntary vocalizations may also be encoun-
tered throughout the entire tenor of neuropsychiatric disor-
ders, to include movement disorders, neurodegenerative and
neurodevelopmental syndromes, and functional neurological
disorders. Ictal phenomena in epileptic disorders may also
present with vocalizing behaviors. Although in many of
these disorders, abnormal vocalizations will often be only
one feature of a range of abnormal motor behaviors and
clinical signs, in some cases, they may constitute the sole
clinical finding. Here, their early recognition and appro-
priate classification are paramount for guiding diagnostic
reasoning and informing therapeutic decisions. However,
beyond tic disorders and TS, the clinical literature on the
topic remains sparse,2 and video-documented cases are
particularly rare.
Over a period of several years, we came across a num-
ber of patients in whom abnormal vocalizations were the
predominant reason for clinical presentation. Given the
difficulties in the phenomenological classification of
vocalizing behaviors, we here provide a clinical overview
of the range of involuntary vocalizations in humans,
together with 29 informative video-documented cases, to
illustrate both typical and more unusual clinical exam-
ples. Our goal is to inform our colleagues from the neigh-
boring fields of neurology, neuropsychiatry, and
psychiatry on the phenomenological spectrum and diag-
nostic conditions associated with involuntary vocaliza-
tions, discuss their pathophysiology, and provide
treatment recommendations where possible.
Methods
Data from 5 expert centers of movement disorders
across Europe (Department of Neurology, Charité Univer-
sity Medicine Berlin, Berlin, Germany; Department of Clin-
ical and Movement Neurosciences, Queen Square Institute
of Neurology, University College London, London, UK;
Department of Neurology, University Hospital Schleswig-
Holstein, Christian-Albrechts-University, Kiel, Germany;
Department of Neurology, University Medical Centre
Groningen, University of Groningen, Groningen, The
Netherlands; Clinic of Psychiatry, Socialpsychiatry and
Psychotherapy, Hannover Medical School, Hannover,
Germany) were pooled for this study. Cases of patients
in whom involuntary vocalizations predominated in
clinical presentation and for whom video material was
available were first collected and reviewed. We selected
the cases that exemplified distinct phenomenological
characteristics of different vocalizing behaviors. We
also reviewed the literature to identify the range of pos-
sible etiologies associated with the different types of
vocalizing behaviors that we included and to explore
treatment options. Based on our clinical experience and
the available material we gathered, we also provide
practical treatment recommendations where possible.
Signed patient consent was obtained for videos of all
patients that we present here.
Tics and Tic-Like Vocalizations
Tics are defined as movements or sounds that resemble
physiological motor behaviors, but are typically inoppor-
tune to social context and appear sudden, repetitive, and
often exaggerated.4 Tic vocalizations— commonly termed
vocal or phonic tics—may include any possible sound (eg,
sniffing, coughing, throat clearing, whistling, or grunting),
word, or sentence and are most commonly encountered
within the spectrum of primary tic disorders, as TS (Video
1A–C). In these patients, tics, including phonic and vocal
behaviors, are typically preceded by premonitory urges and
can be suppressed voluntarily.4-7 Individuals with autism
spectrum disorders (ASD) may also present with vocal tics,
and indeed an overlap between primary tic disorders and
autistic features has been reported in the medical litera-
ture.8,9 However, in ASD premonitory urges and overall
vocal tic awareness may be reduced compared to people
with primary tic disorders and TS.10 Klinefelter,11 fragile
X,12 and Adams-Oliver syndrome,13 as well as monosomy
9p14 and trisomy 16p15 are documented genetic causes of
other neurodevelopmental disorders that may manifest
phonic/vocal tics. Neurodegenerative syndromes may also
present with phonic or vocal tics, for example, in
Huntington’s disease (Video 1D). Here, vocalizing behaviors
such as grunting tics are often characteristic (Video
1E,F),16-18 and although the distinction of tics from choreic
sounds (also see the section onVocalizations as Part ofDysto-
nia, Chorea, and Other Dyskinesias) may often be difficult,
some patients describe the presence of premonitory urges pre-
ceding vocal tics (case example of video 1E). Furthermore,
vocal tics have been documented in patients with chorea-
acanthocytosis because of VPS13A mutations19-21 (Video
1G), Amyotrophic lateral sclerosis (ALS) frontotemporal
dementia (FTD) overlap syndromes,22 progressive supra-
nuclear palsy (PSP),23 and pantothenate kinase-associated
neurodegeneration (PKAN).24 Neurometabolic disorders
such as Wilson’s disease or phenylketonuria,25,26 focal brain
lesions,27-34 infectious,35-37 and other autoimmune dis-
eases38-41 are additional causes of vocal tics (see Table 1).
Finally, phonic or vocal tics may also be drug-induced, either
directly related to the acute effects of drugs42-46 (eg, cocaine46)
or as a long-term consequence, such as in tardive tic
disorders47-49 (Video 1H).
A final etiological category includes functional neurologi-
cal disorders. Previous literature on such cases refers to
repetitive sounds resembling vocal tics as tic-like vocaliza-
tions and offers clinical clues to distinguish the 2 types of
behaviors.50-53 Abrupt symptom onset, typically in
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TABLE 1. Spectrum of involuntary vocalizations in humans, their descriptions, and etiologies









— Primary tic disorders (eg, TS)
— Other neurodevelopmental disorders (eg, ASD, Klinefelter, fragile X, Adams-Oliver
syndrome, monosomy 9p, trisomy 16p)
— Neurodegenerative disorders (eg, HD, chorea-acanthocytosis, ALS-FTD overlap syndromes,
PSP, PKAN)
— Neurometabolic disorders (eg, Wilson’s disease, PKU)
— Focal brain lesions (eg, after head trauma, arteriovenous hemorrhage, following cardiac
surgery, after temporal lobectomy, in osmotic demyelination syndrome, after carbon
monoxide poisoning, postinfectious (VZV encephalitis))
— Infectious (eg, HIV, HSV, rubella virus)
— Autoimmune (eg, postinfectious, MS, SLE, Behcet’s disease, antiphospholipid syndrome)
— Drug-induced (eg, carbamazepine, lamotrigine, bupropion, cocaine)
— Tardive (eg, antipsychotics)
— Functional neurological disorders
• Klazomania Compulsive shouting episodes — Primary tic disorders (eg, TS)
— Focal brain lesions (eg, carbon monoxide poisoning)
— Others (eg, depressive disorders, postencephalitic parkinsonism)
— Functional neurological disorders
• Palilalia Repetition of one’s own
syllables, words, or
phrases 2 or more times in
a row
— Primary tic disorders (eg, TS)
— Other neurodevelopmental disorders (eg, ASD, trisomy 16p)
— Neurodegenerative disorders (eg, Alzheimer’s disease, PSP, chorea-acanthocytosis, VCP
proteinopathy, PDa)
— Focal brain lesions (eg, ischemic, hemorrhagic, after stereotaxic thalamotomy, after severe
head trauma, after carbon monoxide poisoning, after respiratory acidosis, associated with
extensive intracerebral calcifications, postinfectious [VZV encephalitis])
— Ictal
— Autoimmune (eg, steroid-responsive encephalopathy)
— Drug-induced (eg, clozapine, cefepime)
— Others (eg, early-onset schizophrenia, membranous lipodystrophy, postencephalitic
parkinsonism)
— Functional neurological disorders (including startle syndromes, eg, Latah)
• Echolalia Imitative repetition of sounds,
words, or phrases in the
absence of explicit
awareness
— Primary tic disorders (eg, TS)
— Other neurodevelopmental disorders (eg, ASD, Rubinstein-Taybi, fragile X, Williams
syndrome, trisomy 16p)
— Neurodegenerative disorders (eg, DLB, FTD, Alzheimer’s disease, HD, CJD, PSP-CBS, CBD,
familial progressive subcortical gliosis, chorea-acanthocytosis)
— Neurometabolic disorders (eg, Wilson’s disease, NPC, encephalopathy in D-lactic acidosis,
after liver transplantation)
— Focal brain lesions (eg, ischemic, after severe head trauma, after carbon monoxide
poisoning)
— Infectious (eg, cerebral malaria)
— Autoimmune (eg, Hashimoto’s encephalopathy, MS, NMDA-receptor encephalitis, SLE)
— Drug-induced (eg, isoniazid, topiramate, ofloxacin, methoxphenidine, cocaine, designer
tryptamine, phencyclidine)
— Functional neurological disorders (including startle syndromes, eg, Jumping Frenchmen of
Maine, Latah, Ragin’ Cajuns of Louisiana)
— Others (eg, encephalitis lethargica, catatonia)




— Primary tic disorders (eg, TS)
— Other neurodevelopmental disorders (eg, Kleine-Levin syndrome, fragile X syndrome)
— Neurodegenerative disorders (eg, FTD, Alzheimer’s disease, choreo-acanthocytosis)
— Focal brain lesions (eg, after carbon monoxide poisoning)
— Ictal
— Functional neurological disorders







— Physiological, normal development
— Neurodevelopmental disorders (eg, ASD, 15q13.3 microdeletion, Rett syndrome)
— Others (eg, schizophrenia)
(Continues)
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adulthood, absence of premonitory urges, lack of suppress-
ibility, and atypical response to anti-tic medication, along-
side the presence of further functional movement disorders
and medically unexplained symptoms, are indeed charac-
teristic red flags that should prompt the consideration of a
functional etiology. However, even with these helpful aids,
correct diagnostic labeling and etiological distinction may
often be challenging, particularly in cases in which both tics
and tic-likemovements or soundsmay co-occur.4,54
Klazomania
The term klazomania (after the Greek word for “cry-
ing”) was first coined in 1925 by Benedek, a German
psychiatrist, who described a patient with postencephalitic
parkinsonism and involuntary attacks of compulsive
paroxysmal shouting.55 The shouting behaviors were
described as extremely loud and not related to the ongoing
mental state of the patient. They occurred in bouts and
could last for several hours. Syllables, vowels, single words,
and sometimes noises, described in the original report as
“carnivorous” animal sounds, were noted.55 Palilalic
behaviors (see below) were also described in this patient,
who was able to briefly suppress the involuntary vocaliza-
tions with forceful breathing. Inappropriate shouting is
also a well-documented feature in TS56 (Video 1I) and
functional neurological disorders (Video 1J). Other associ-
ations of klazomania include depression57-59 and carbon
TABLE 1. Continued










— Neurodegenerative disorders (eg, HD, chorea-acanthocytosis)
— Autoimmune (eg, postinfectious)








grunting, and shrieking in
the absence of appropriate
context
— Neurodegenerative disorders (eg, Alzheimer’s disease, vascular dementia, HD, PD, PSP)
— Neurometabolic disorders (eg, acquired hepatocerebral degeneration)
— Functional neurological disorders
Pathological laughter
and crying
Laughter and crying occurring
detached from emotional
content
— Primary tic disorders (eg, TS)
— Other neurodevelopmental disorders (eg, Angelman syndrome, partial trisomy 16p, Rett-like
syndromes)
— Neurodegenerative disorders (eg, ALS, FTD, Alzheimer’s disease, primary progressive
aphasia, MSA-C, CJD, SCA17, HD)
— Focal brain lesions (eg, cerebrovascular disease, traumatic brain lesions)
— Ictal (eg, gelastic seizures)
— Autoimmune (eg, acute disseminated encephalomyelitis, MS)





Repetitive sounds such as
belching, sniffing,
coughing, wheezingb
— Physiological (eg, contagious yawning, groaning during sexual intercourse)
— Primary tic disorders (eg, TS)
— Neurodegenerative disorders (eg, as OFF symptom in PD)
— Focal brain lesions (eg, ischemic)
— Ictal (eg, seizure-ending signs, temporal lobe seizures)
— Infectious (eg, herpes simplex encephalitis)
— Functional neurological disorders
Others Broad range of involuntary
vocalizations not clearly
belonging in any of the
previous categoriesb
— Culture-bound startle syndromes
— Functional neurological disorders (eg, exaggerated stimulus-triggered responses)
— Ictal (eg, ictal cry, animal noises, singing, and humming)
— Sleep related (eg, snoring, catathrenia, stridor [eg, in MSA, anti-IgLON5 disease, SCA17]),
— Night terrors
— Sleep-related hypermotor seizures
— REM sleep disorder in primary tic disorders (eg, TS), neurodevelopmental disorders (eg,
ASD), neurodegenerative disorders (eg, PD, MSA, DLB, FTD, ALS, SCA3, xeroderma
pigmentosum, HD), focal brain lesions (eg, brain stem ischemia, tumors) autoimmune
disorders (eg, MS, Guillain-Barré syndrome, paraneoplastic), and others (eg, narcolepsy,
epilepsy, posttraumatic stress disorder)
ALS, amyotrophic lateral sclerosis; ASD, autism spectrum disorder; CBD, corticobasal degeneration; CBS, corticobasal syndrome; CJD, Creutzfeld-Jacob dis-
ease; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; HD, Huntington’s disease; HIV, human immunodeficiency virus; HSV, herpes simplex virus;
MS, multiple sclerosis; MSA-C, multiple system atrophy–cerebellar type; NPC, Niemann Pick type C; PD, Parkinson’s disease; PKAN, pantothenate kinase-
associated neurodegeneration; PKU, phenylketonuria; PSP, progressive supranuclear palsy; REM, rapid eye movement; SCA, spinocerebellar ataxia; SLE, sys-
temic lupus erythematosus; TS, Tourette syndrome; VCP, valosin-containing-protein; VZV, varicella zoster virus.
aMay occur in association with peak-dose levodopa or as side effect of deep brain stimulation.
bSome sounds are mediated by supraglottic structures without involvement of the larynx.
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monoxide poisoning.60,61 Clearly, as in the distinction of
tics from tic-like vocalizations, beyond phenomenological
observation of vocalizing behaviors, historical information
and the presence of additional clinical features are crucial
to distinguish between the different etiological categories.
Palilalia
Palilalia is the involuntary repetition of one’s own
phrases, words, or syllables 2 or more times in a row.62
Typically, palilalic utterances decrease in volume with
the increasing number of repetitions.63 Sometimes, the
repetitions are also uttered with an accelerating
speed.62,64
In 1908, Souques first described palilalia in a patient
with an ischemic stroke of the right hemisphere.62 Since
then, palilalia, which is typically documented in up to a
third of patients with TS56,65-67 (Video 1A), was reported
in patients with other neurodevelopmental disorders such
as ASD68 or trisomy 16p15 and neurodegenerative disor-
ders, such as PSP,69,70 dementia of the Alzheimer’s type,71
valosin-containing-protein proteinopathy,72 or chorea-
acanthocytosis73 (Video 1G). In patients with typically
advanced parkinsonism, palilalia may also be observed
either irrespective of their medication status74 or in associ-
ation with peak doses of levodopa75 and as a side effect
of bilateral stereotaxic thalamotomy, most likely as the
effect of lesions.76 Focal brain lesions, typically affecting
thalamic and/or midbrain structures, may also lead to the
expression of palilalic behaviors.34,60,62,76-85 A family
with extensive intracerebral calcification was reported to
present palilalia,86 and indeed patients with Fahr syn-
drome, an etiologically heterogeneous disorder,87 will
often present this clinical sign. Further, palilalia was
reported as ictal,88 autoimmune,89 and drug-induced phe-
nomenon (eg, with clozapine90 or cefepime91).
Like klazomania, palilalia was also observed in patients
with encephalitis lethargica and postencephalitic parkin-
sonism.62,64,92-94 Other reported etiologies are early-onset
schizophrenia95 andmembranous lipodystrophy.96 Finally,
palilalic behaviors may also be encountered in functional
neurological disorders52 and in culture-bound startle syn-
dromes (eg, Indonesian Latah; also see below).97 Of note,
palilalia should be distinguished from stuttering, a disorder
with dysfluency of speech and repetition of sounds, sylla-
bles, or words (eg, Video 1A, palilalia vs Video 1K,
stuttering).98,99
Echolalia
Echolalia is the automatic imitative repetition of
sounds, words, or phrases in the absence of explicit
awareness.100 Although echolalia constitutes a physio-
logical neurodevelopmental phenomenon, its unremitting
persistence or reemergence may point to pathology.100
As with the majority of involuntary vocalizing behaviors,
the prevalence and exact characteristics of echolalia in differ-
ent disorders remain understudied.101 However, it is most
commonly reported in TS66,102 and ASD.103-106 Patients
with other neurodevelopmental disorders,15,107-110 including
fragile X108,109 andWilliams syndrome,110 and neurodegen-
erative syndromes (eg, dementia with Lewy bodies,111 vari-
ous tauopathies,112-117 HD,118 Creutzfeldt-Jakob disease
(CJD),119 and chorea-acanthocytosis73) may also present
with echolalia. Neurometabolic disorders, such asNiemann-
Pick typeC (Video1L) andWilson’s disease120 or encephalo-
pathic syndromes,121-123 as well as brain lesions due to focal
or diffuse cerebrovascular damage,114,124 carbon monoxide
poisoning,60 and severe head trauma85 were also associated
with echolalic behaviors. Infections (eg, cerebral malaria125)
and autoimmune disorders such as N-methyl-D-aspartate
(NMDA)–receptor encephalitis,126 systemic lupus
erythematosus,127 and others128,129 may also present with
echolalia. Drug-induced echolalia was noted with
isoniazid,130 topiramate,131 ofloxacin,132 the NMDA-
receptor antagonist methoxphenidine,133 cocaine,134
designer tryptamine,135 and phencyclidine (“angel dust,”
“crystal”).136 Other underlying causes of echolalia are
encephalitis lethargica,94 catatonia,137 functional neurologi-
cal disorders (Video 1M101), and endemic startle syndromes
such as the Jumping Frenchmen of Maine,138 Latah,97 and
the Ragin’ Cajuns of Louisiana.139 Indeed, in this latter
group of etiologies, echolalic behaviors are characteristic.
Coprolalia
The exact definition of coprolalia in the medical con-
text has been tortuous. Essentially, coprolalia denotes
the involuntary utterance of obscenities.52 Intent is an
important classifier in coprolalic behaviors, and unfortu-
nately it remains unclear how to objectively distinguish
coprolalia from common swearing. In TS, the unintended
expression of coprolalic behaviors is encountered in about
one-fifth of patients.140 Typical coprolalic behaviors in
TS are characterized by the utterance of single short—in
the English language, 4-letter—words with a different
pitch or tone from ongoing speech.
There have been only a few reports of patients exhibiting
coprolalia in other neurological conditions, such as neu-
rodevelopmental disorders (eg, Kleine-Levin141 and fragile
X syndrome12), neurodegenerative syndromes (eg, FTD,142
Alzheimer’s disease,143 and chorea-acanthocytosis144), after
focal brain lesions60, in encephalitis lethargica94, or as ictal
phenomenon.145 A final category includes functional neu-
rological disorders, and often these patients may be misdi-
agnosed with TS, although their clinical characteristics
may largely differ.52 Indeed, different from coprolalia in
TS, functional coprolalic behaviors often comprise short
sentences with obscene content. Most importantly, many
of these behaviors are also context dependent (see Video
1N). A previous history of medically unexplained
1778 Movement Disorders, Vol. 34, No. 12, 2019
M A I N K A E T A L
symptoms and further documented functional neurological
signs are typically present.52
Vocalizations as Part of Stereotypies
The precise definition of stereotypies and their exact phe-
nomenological distinction from other repetitive motor
behaviors, for example, tics, is difficult.146 The term
denotes a repetitive, often continuous, non-goal-directed
movement pattern that is typically distractible.146 As with
echolalic behaviors, stereotypies are also part of physiolog-
ical development that often abate within the first years of
life.146 Although the persistence of stereotypic vocaliza-
tions may still be part of normal development,147 in many
cases it signifies pathology, and indeed stereotypic utter-
ances are part of the diagnostic criteria of ASD (Video
2A).3 One large case series of 83 patients with Rett syn-
drome described phonic stereotypies with repetitive
sounds, words, or phrases in only 6% of patients.148 We
recently observed loud stereotypic vocalizations in a
patient with 15q13.3 microdeletion syndrome (Video 2B)
and late-treated cases with phenylketonuria. Further, ste-
reotypic vocalizations have been documented in patients
with schizophrenia.149
Vocalizations as Part of Dystonia, Chorea,
and Other Dyskinesias
Involuntary sounds may also be part of dystonic and
choreic disorders. For example, lip-smacking sounds
(Video 3A) and panting and gasping (Video 3B) are char-
acteristic presentations of drug-related, usually tardive syn-
dromes. Most recently, we documented a case with
generalized dyskinetic movements and loud utterances fol-
lowing treatment with lenalidomide (Video 3C). A similar
case, albeit without video documentation, was also
recently reported.150 In chorea-acanthocytosis, beyond the
presence of tic vocalizations, sounds such as belching, spit-
ting, clicking, sniffing, grunting, sucking, blowing, gasping,
sighing, or monosyllabic utterances may be observed.151
In HD, lip-smacking and grunting (also see below) are fre-
quently reported. In a large cohort of patients with
Sydenham’s chorea, 8% presented with simple vocaliza-
tions (tongue clicking, throat clearing, sniffing) not pre-
ceded by premonitory sensations, but in association with
facial chorea in most of the patients.152 It was proposed
that the sounds are generated by involuntary choreic acti-
vation of pharyngeal and laryngeal muscles.152
Continuous Vocalizations Such as Groaning,
Moaning, Grunting, and Shrieking
Continuous groaning, moaning, grunting, and
shrieking are most frequently associated with neurode-
generative diseases. For example, in dementias, such as
Alzheimer’s disease153,154 and others153,154, to include
HD, continuous involuntary vocalizations, often
labeled as vocally disruptive behavior, are part of a
spectrum of behavioral symptoms that correlate with
the severity of cognitive impairment155 and may be
exacerbated with emotional arousal (Video 4A). Pur-
poseless noisemaking, for example, groaning or howl-
ing in parkinsonism156 (Video 4B), including PSP157-159
(Video 4C), may also be encountered. We also docu-
mented continuous shrieking in a patient with acquired
hepatocerebral degeneration during an episode of
acute encephalopathy (Video 4D). Finally, functional
neurological disorders may also present with continu-
ous sounds, such as grunting (Video 4E) or shrieking
(Video 4F).
Pathological Laughter and Crying
Laughter and crying behaviors that occur detached
from emotional content were reported in patients with TS
as part of tic behaviors160 and other neurodevelopmental
disorders (eg, Angelman syndrome,161 partial trisomy
16p,15 and Rett-like syndromes162). However, pathologi-
cal laughter and crying is most commonly associated with
neurodegenerative disorders, such as ALS,163 FTD,164
Alzheimer’s disease,165 primary progressive aphasia,166
multiple system atrophy cerebellar type,167 CJD,168 spi-
nocerebellar ataxia (SCA) 17,169 and HD. Focal brain
lesions in cerebrovascular disease,170-177 traumatic brain
injury,178-180 autoimmune-mediated lesions in dissemi-
nated encephalomyelitis181-183 or drug-induced behavior184
are additional etiologies. Finally, recurring “automatic”




Typical vocalizations related to physiological reflexes
are sniffing, throat clearing, belching, and wheezing,
whereby these audible sounds are mediated by sup-
raglottic structures without involvement of the larynx.
Sniffing and throat clearing are noises that are fre-
quently encountered as habitual behaviors (eg, throat
clearing in concert halls) and as simple vocal tics in
patients with TS.66 Persistent coughing as a vocal tic
can be misinterpreted as disease of the upper and lower
airways.187,188 An extraordinary cause of belching was
seen in a patient with parkinsonism, who suffered from a
disturbance of esophageal motility with consecutive
belching during OFF-periods that remitted with levodopa
intake.189 Persistent hiccups were reported after ischemic
lesions of the brain stem.190,191 Sounds such as coughing
or throat clearing may also present either as ictal phenom-
ena192,193 or “seizure-ending signs.”194 Belching in combi-
nation with aerophagia was described in a patient
following herpes simplex encephalitis.195 Sniffing,
coughing, belching (Video 5A), and hiccup-related sounds
(Video 5B) were also documented in functional neurologi-
cal disorders.52,196 Other physiological involuntary
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vocalizations are “contagious yawning”197 or groaning
during sexual intercourse.198
Others
This group encompasses involuntary vocalizations that
may not clearly belong in any of the previous categories
and may represent distinctive phenomena of specific eti-
ologies. For example, patients with culture-bound startle
syndromes, such as Latah (also see section on palilalia),
typically vocalize following a loud external stimulus.97
Patients with functional movement disorders may also
show similarly exaggerated stimulus-triggered responses
(Video 6). This type of vocalized startling differs from
the classic motor startle response in hyperekplexia. In
the classical hereditary forms of hyperekplexia, the
latency of the stereotypic spread of muscle activation is
very short, whereas in the neuropsychiatric forms the
latency is longer and includes a secondary phase with
vocalization.199
Another important category encompasses ictal phe-
nomena. Ictal vocalizations (also see previous sections)
may inherently cover the entire tenor of possible sounds
and phonemes of humans: from the classic “ictal cry,”
signifying the beginning of generalized tonic-clonic
seizures,200 over echo-, pali-, and coprolalic145,201-204
behaviors, to animal noises (“bleating of sheep,”
barking),205,206 singing, and humming.207-209 Of note,
weeping, moaning, and coughing may also be encoun-
tered in nonepileptic seizures.200
A final category includes noisemaking during sleep. In
addition to common snoring, which is the result of
obstructed air movement in the upper airways leading to
vibration of the soft palate and posterior faucial pillars,210
other sleep-related sounds include strictly expiratory
groaning and moaning, known as catathrenia.211 In neuro-
degenerative disorders, such as multiple system atrophy
(MSA)212 or SCA17,213 stridor during sleep is a common
feature. In anti-IgLON5 syndromes, a prominent stridor in
association with REM sleep behavior disorder (RBD) does
frequently occur.214 RBD itself may also be associated with
vocalizations such as laughing, talking, shouting, and swear-
ing. It has been described in TS215 and autism.216 Most
commonly, however, RBD occurs in neurodegeneration (eg,
α-synucleinopathies,217-220 tauopathies,219,221,222 and
others223-228; see Table 1). RBDwas also reported as a result
of focal brain lesions, particularly within the brain stem fol-
lowing stroke229-231 or due to tumors,232 and in autoim-
mune disorders, such as multiple sclerosis,233 Guillain-Barré
syndrome,234 and paraneoplastic encephalitis.235 It has also
been described in association with narcolepsy,236
epilepsy,237 and posttraumatic stress disorder.238 Finally,
vocalizations during sleep can be related to night terrors239
or sleep-related hypermotor seizures.240 Figure 1 provides a
diagnostic algorithm on how to etiologically approach the
different involuntary vocalizations described here.
Pathophysiology of Involuntary Vocalizations
The physiology of vocalizing behaviors relies on a well-
coordinated network of respiratory, laryngeal, and
supralaryngeal muscles.241 The motoneuronal pool under-
lying the innervation of these motor effectors is wide-
spread between pontine segments of the brain stem (eg,
for the control of jaw-closing muscles) over to motor neu-
rons of the upper lumbar spinal cord (eg, innervation of
abdominal muscles).241 The coordination of this extensive
neuronal network is accomplished by superordinate neu-
ral structures, which control and maintain the different
elements of vocalizing behaviors to include vocal reflexes
(eg, shrieking or crying as a result of a painful stimulus),
imitative vocalizations, and human speech.242 Extensive
research in a wide range of mammals, including humans,
has revealed 2 basic networks underlying vocalization
behaviors with overlapping output structures.242 A
cingulo-periaqueductal network has been associated with
FIG. 1. Diagnostic algorithm for the approach of patients with involuntary vocalizations. aMRI might be normal, bmay also occur with other neuropsychi-
atric or neurological signs. AD, Alzheimer’s disease, ALS, amyotrophic lateral sclerosis, ASD, autism spectrum disorder, CA, chorea-acanthocytosis,
CJD, Creutzfeld-Jacob Disease, FTD, frontotemporal dementia, HD, Huntington’s disease, MS, multiple sclerosis, NBIA, Neurodegeneration with Brain
Iron Accumulation, NPC, Niemann Pick type C, PD, Parkinson’s disease, PSP, progressive supranuclear palsy, SLE, systemic Lupus erythematodes,
TS, Tourette syndrome. Also refer to table 1 for complete list of etiologies associated with involuntary vocalizations.
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the control of patterned vocalizations related to the gating
of reflexes, such as nonverbal emotional responses (eg,
crying, moaning, shrieking, and laughing). The supple-
mentary motor area together with the motor cortex, the
cortico-striato-thalamo-cortical pathways, and a wider
network extending to the pontine gray and cerebellar
pathways regulate fine motor control and learned vocali-
zations, such as the ability to speak and sing. Figure 2
provides a simplified representation of the key neural
structures underlying human vocalizing behaviors.
Unfortunately, despite the advances in the field of
vocalizations, most pathological phenomena reported
here remain scientifically understudied. However, phe-
nomenological observations and cross-species comparative
behavioral and neuroanatomical studies, including lesions
and chemical and electrical stimulation protocols
(reviewed in reference 242) provide important insights into
the neuronal structures involved in the different patholo-
gies we present here. Research in tic and tic-like vocaliza-
tions implicates 2 key pathophysiological mechanisms for
repetitive vocalizations. First, local disinhibition within the
cortico-basal ganglia-thalamo-cortical loops that control
motor behavior is suggested to lead to amplified output
gain. This has been demonstrated in primate and rodent
models of tic-like behaviors243,244 and was further
supported by neuropathological studies in patients with
TS.245,246 A single study examined the neuronal locus of
disinhibition to produce repetitive grunting sounds, labeled
as tic-like behaviors in monkeys, and highlighted the char-
acteristic involvement of the nucleus accumbens and the
anterior cingulum, as part of the cingulo-periaqueductal
network, underlying these behaviors.247 As tic vocaliza-
tions range from simple nonverbal utterances, such as
sniffs or grunts, to words and complete sentences, it is
likely that structures of both the cortico-striato-thalamo-
cortical and the limbic cingulo-periaqueductal networks
are involved in the generation of vocal tics. In turn, patho-
logically increased output gain, including vocalizations,
is further selectively reinforced through enhanced stimulus-
response learning via dopaminergic input — here, vocaliz-
ing tics receive behavioral salience.248 The efficacy of
antidopaminergic medication (also see below) to treat tic
vocalizations corroborates the pathophysiological role of
reinforcement learning. Most importantly, disinhibition
and enhanced reinforcement learning may either be the
result of a neurodevelopmental disorder, as in primary tic
disorders, or due to brain damage, as in frontal lobe syn-
dromes or neurodegeneration (also see Tics and Tic-Like
Vocalizations section).
It remains unclear why in certain conditions, as in HD,
for example, vocal tics such as grunting may often be very
specific. In one account, the most commonly employed
motor programs would also have the highest probability
of being part of tic behaviors. For example, in primary tic
disorders, patients mostly exhibit their tics at the motor
effectors, which they most commonly employ in their
daily living (eg, blinking). In light of the phenomenologi-
cal overlap between choreic involuntary vocalizations,
which may also lead to expiratory gasping, sniffing, or
grunting, this view predicts that patients with choreic
grunting would also have a high probability of developing
grunting tics. Indeed, a clear clinical distinction between
choreic grunts and grunting tics may in many cases be
notoriously difficult (Video 1E,F vs Video 1G).
Different to tics, vocalizations as part of stereotypies
remain less well explored. Certain clinical facts, as for
example the absence of a premonitory urge in stereotypies
and their typically continuous nature, imply distinct func-
tional neuroanatomical correlates, even though the
cortico-basal ganglia-thalamo-cortical circuitry has also
been involved.249-251 The fact that stereotypies can fre-
quently be observed in both humans and animals during
confinement and sensory isolation also highlights the sig-
nificance of self-stimulation in their emergence and
maintenance.252,253
The pathophysiology of involuntary sounds as part of
dystonia, chorea, and other dyskinesias, is intrinsically
related to the nature of the involuntary movements254-256
and is beyond the scope of this article. Indeed, the vocalizing
sounds are the result of involuntary activation of structures
related to the respiratory and vocal apparatus, but do not,
we posit, involve higher-order neural processes that produce
patterned behaviors such as speech. Beyond the few neuro-
degenerative choreic disorders we have included, most syn-
dromes we have identified are drug-induced, and indeed
extensive literature exists about the pathophysiology of
drug-induced movement disorders, including vocalizations
(for example, reviewed in references 257 and 258). Video 3C
demonstrates lenalidomide-induced vocalizations as part of
a choreodystonic syndrome. Only one similar case has been
FIG. 2. Simplified representation of the 2 main functional neuroanatomical
networks involved in vocalizing behaviors. Left, a motor-cortical-striato-
thalamo-cortical network underlying control of learned vocalizations (eg,
speaking and singing). Right, a limbic cingulo-periaqueductal network
regulating gating control of patterned reflex vocalizations (eg, nonverbal
emotional responses, such as crying or moaning). Adapted by references
241 and 242. PAG, periaqueductal gray; SMA, supplementary motor
areas; M1, primary motor cortex. [Color figure can be viewed at
wileyonlinelibrary.com]
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documented previously.150 Although the exact mechanism
of action remains unclear, we do wish to note the unusual
and dramatic side effect of thismedication.259
One particular category includes continuous vocaliza-
tions, including groaning, moaning, grunting, and
shrieking. We previously published a case (Video 4C) in
which we highlighted the role of distinct neural generators
in vocalizing behaviors. We postulated that continuous
groaning could be the result of ongoing activation of the
cingulo-periaqueductal circuit, described above (also see
Fig. 2), as a result of either enhanced excitation, reduced
top-down inhibition, or both.159 Given the common
denominator of many of the disorders we report here linked
to frontal lobe damage, we suggest that loss of inhibitory
control over a subcortical cingulo-periaqueductal circuit
involved in the generation of nonverbal utterances could
lead to these types of behaviors.159,242 Additional factors,
such as enhanced limbic drive and dysfunction of the
serotonergic system,260 may further strengthen and/or per-
petuate these behaviors. We suggest that the pathophysiol-
ogy of pathological laughter and crying also falls within
this pathophysiological category — with the exception of
gelastic seizures as ictal phenomena, which are typically
associated with hypothalamic hamartomas.261,262 Epileptic
activity of the frontal lobes, including the anterior cingulate
cortex,263-266 but also parietal267 and temporal lobes,268
has also been reported to give rise to gelastic seizures.
Within the group of vocalizations and sounds that
resemble physiological reflexes, the most common etiolo-
gies are indeed tics (also see above) and functional neuro-
logical disorders. The pathophysiology of functional
neurological disorders, including movement disorders, has
been reviewed before.269-271 It is important to note that
tics, vocalizations as part of stereotypies and vocalizations
as part of a functional disorder, are typically distractible.
This highlights that for these particular vocalizing behav-
iors, superintending centers related to attention and
potentially motivation can alter the output gain based on
environmental context.
In ictal vocalizations, the behavioral abnormality
depends on the cortical locus of abnormal neuronal exci-
tation. For example, seizures over the temporal lobe typi-
cally elicit various types of different vocalizations, such
as animal noises, coprolalia, throat clearing, and
belching.192,193,201,205 Similar vocalization behaviors
have also been described for epileptic discharges over
mesiofrontal brain areas, including the supplementary
motor area and the anterior cingulate cortex.242,272
Finally, vocalizations in REM sleep disorder are
suggested to result from dysfunction of the nucleus sub-
coeruleus and/or the reticular formation, whose gluta-
matergic, GABAergic, and glycinergic projections fail to
inhibit spinal motor neurons, and thus muscle atonia is
no longer induced.273 Neurodegenerative disorders, such
as PD,274 MSA, DLB, and PSP,275 with abnormalities in
REM sleep behavior typically affect these structures, and
indeed the reticular formation is a key structure for the
activation of the motor neuronal pool involved in vocali-
zations (Fig. 2).
Treatment Options
Within the range of the different involuntary vocaliza-
tions, the treatment strategy depends on the vocalization
type and the underlying etiology. However, beyond the
treatment of tics, therapeutic interventions in other types
of vocalizations are mostly based on case series and single
case reports. For tic vocalizations, as in the example of pri-
mary tic disorders, there are 3 main therapeutic venues:
(1) behavioral treatments, including habit reversal training
and its expansion, the comprehensive behavioral interven-
tion for tics (CBIT) (for a review, see reference 276;
(2) pharmacological interventions, such as antipsychotics,
dopamine-depleting agents, α2-agonists, and more recently
cannabinoids277-279 (3) surgical interventions for refrac-
tory cases, such as deep brain stimulation.280 In addition,
local injections of botulinum toxin might also alleviate
symptoms.281 Single case reports have indicated that other
medications might also be helpful. For example, fluoxetine
was used to control laughing tics in TS.160 However, the
efficacy of these treatments remains understudied. An
important caveat is the treatment of tic-like behaviors in
functional neurological disorders in which behavioral ther-
apies should be preferred over pharmacological
agents.50-52,54,282
In klazomania, particularly in the presence of depression
and anxiety, benzodiazepines showed some therapeutic
promise in 1 case, whereas quetiapine, risperidone,
aripiprazole, amitriptyline, and sertraline were ineffec-
tive.57 Electroconvulsive therapy was also reported to be
effective in 2 patients with klazomania and depression.57,58
Treatment reports specifically targeting pali-, echo-,
and coprolalia are particularly rare. Palilalia in vascular
dementia was responsive to the antidepressant trazo-
done.283 In some cases of echo- and coprolalia, benzo-
diazepines led to the alleviation of symptoms.94,123 The
amphetamine-related drug fenfluramine was efficient in the
reduction of echolalia in 10 patients with ASD.107 Echola-
lia in a case with a left temporoparietal hemorrhage and a
case with a diagnosis of Rubinstein-Taybi syndrome
improved after behavioral therapy.107,284 We believe that
behavioral therapy should be a first-line option in patients
with repetitive vocalizing behaviors, such as pali-, echo-, or
coprolalia, but also in cases with vocalizations as part of
stereotypies. However, in some of these cases, particularly
in the presence of additional behavioral abnormalities,
pharmacological augmentation may be necessary.
In vocalizations as part of dystonia, chorea, or other
dyskinesias, the most common etiology is drug-induced.
In these cases, the causing agent should be removed if
possible, or dosage should be reduced. In addition, the
prescription of dopamine-depleting agents might be
helpful.2
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Although being a huge burden in hospitals and nursing
homes, specific treatment for continuous vocalizing behav-
iors, such as those associated with neurodegeneration, is
poorly investigated. A detailed assessment about whether
other circumstances such as physical or mental suffering
(pain, discomfort, fatigue, frustration, depressed mood, dep-
rivation, etc.) could elicit or precipitate the vocalizing
behavior is recommended. The recognition and removal of
these factors could lead to a remission of vocalizing behav-
iors. In addition, behavioral interventions such as avoidance
of positive reinforcement of vocally disruptive behavior
could be helpful.285 Pharmacological approaches include
tranquilizers, antipsychotics, anticonvulsants, antidepres-
sants, and beta-blockers, however, with mixed
responses.154 In the absence of randomized, controlled
studies, the antidepressants paroxetine,286 citalopram,287
trazodone,288,289 and doxepine290 were shown to reduce
vocalizing behavior in single cases and case series.
Although reported to be the most effective,155 benzodiaze-
pine285 intake should be monitored with caution to main-
tain functionality and mobility. In cases with concomitant
aggression, antipsychotic medication could be helpful, and
in patients with comorbid depression or anxiety, the usage
of antidepressants is preferable.285 Pathological crying after
brain injury was reported to be well controlled with parox-
etine and citalopram in a large case series.291 Intractable
hiccups responded well to inhaled cannabis in a patient
with AIDS.292 Table 2 provides a comprehensive overview
of treatment options in involuntary vocalizations.
Conclusion
We here presented the wide range of involuntary vocali-
zations in humans, together with 29 video-documented
cases to exemplify their phenomenology. Based on these
cases and on the extensive literature review, we provide a
diagnostic algorithm to guide clinicians in approaching
patients with involuntary vocalizing behaviors (Fig. 1),
discuss their pathophysiology, and provide treatment
options, where available. We do recognize that some of
the behaviors that we document reflect sounds emitted
from supraglottic structures, rather than true vocaliza-
tions generated from the vocal cords, and have clearly
documented the differences between these phenomena.
Also, we are aware that the classification of some of the
vocalizations we present as involuntary (eg, tics) may be
open to criticism. However, we do suggest that several of
their qualities, for example, their inflexible, repetitive, and
socially inopportune character, as well as their perception
as unwanted and often distressing phenomena, guarantee a
minimal involuntary component. Our algorithmic
approach may not cover every possible clinical presenta-
tion of involuntary vocalizations and its respective etiology.
Nevertheless, we do hope that it provides a clear frame-
work to guide clinicians in their diagnostic considerations.
This, in turn, will translate to improved pathophysiological
understanding and appropriate management of these para-
digmatic neuropsychiatric patients.
Legends to the Videos
Video 1. Tics and tic-like vocalizations. (A–C) Vocali-
zations in TS. (A) Multiple vocal tics including whistling,








— Antipsychotics (eg, aripiprazole, risperidone,
olanzapine)
— α2-Agonists (eg, clonidine, guanfacine)
— Dopamine-depleting drugs (eg, tetrabenazine)
— Cannabinoids
— Botulinum toxin
— Others (eg, baclofen, topiramate)
DBS
Electroconvulsive therapy (for klazomania)a
Vocalizations as part
of stereotypies
Behavioral therapy (eg, CBT)
Pharmacological treatments
— Antipsychotics (eg, haloperidol, risperidone,
olanzapine)
— Antidepressants (eg, SSRI such as fluoxetine,







— Reduce offending agent if possible








— Practical interventions (eg, relieve discomfort,
provide orientation, avoid excess attention to
vocalizing behavior)
Pharmacological therapy
— Benzodiazepines (eg, lorazepam)
— Antipsychotics (eg, risperidone)
— Antidepressants (eg, tricyclic such as
doxepin, SSRI such as paroxetine, citalopram,
SARI such as trazodone)




— Antidepressants (eg, tricyclic such as
doxepin, SSRI such as paroxetine, citalopram,
and other such as venlafaxine, mirtazapine,
or reboxetine)







CBIT, comprehensive behavioral intervention for tics; CBT, cognitive behav-
ioral therapy; DBS, deep brain stimulation; ERP, exposure and response pre-
vention; HRT, habit reversal training; NMDA, N-methyl-D-aspartate; SARI,
serotonin antagonist and reuptake inhibitor; SNRI, serotonin-norepinephrine
reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.
aTwo case reports.
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grunting, sighing, palilalia (“ja, ja, hallo, hallo, hallo,”
ie, “yes, yes, hello, hello, hello”) and coprolalia
(“scheiße”). Motor (facial twitches) and vocal tics (hum-
ming) started at age 12. Tics were preceded by premoni-
tory urges and were suppressible on demand. The
patient was also diagnosed with obsessive-compulsive
disorder, attention deficit hyperactivity disorder, depres-
sion, and anxiety disorder. (B) Tic vocalizations includ-
ing nonsensical sounds, words (“der Kampf”) and
phrases (“Hilfe, L… stirbt”) including coprolalia. Tic
behaviors first appeared at age 5, waxed and waned over
time, were preceded by premonitory urges, and could be
voluntarily suppressed. (C) Bout of grunting, throat
clearing, and coughing tics in a patient with TS. Motor
and vocal tics were present since the ages of 5 and
12 years, respectively, and waxed and waned with time.
Tics were preceded by premonitory urges and could be
voluntarily suppressed. Severe obsessive-compulsive and
major depressive disorder were also diagnosed. (D–F)
Vocalizations in HD. (D) Shrieking, sniffing and
shouting tics. (E) Characteristic repetitive grunting tics
and sniffing sounds. The patient described a mounting
urge sensation in his larynx preceding and leading to the
release of these sounds. (F) Grunting, throat clearing,
and coughing tics (previously published293). The invol-
untary phenomena could be suppressed for a few sec-
onds until an unpleasant tension and tightness led to
their continuation. (G) Laughter, rasping sounds,
grunting, hissing, snorting, and palilalic utterance of
nonsensical words (“upsa”) in monozygotic twins with
chorea-acanthocytosis (previously published without
video material20). (H) Drug-induced (risperidone and
methylphenidate overdose) lip-smacking tics in a patient
with schizophrenia. He was able to briefly voluntarily
suppress the repetitive lip-smacking movements but
experienced an increasing urge to release them. Treat-
ment with tetrabenazine improved the repetitive behav-
iors. (I) Involuntary shouting (klazomania) in a patient
with TS. Eye blinking was the first tic at age 10, followed
by multiple waxing and waning motor and vocal tics.
Over 2 years the patient presented a complex pattern of
motor and vocal tics with repetitive foot stamping,
flailing movements of the arms, and grimacing alongside
bouts of loud shouting. Severe obsessive-compulsive dis-
order and self-injurious behavior (hitting his head, press-
ing against his eye, scratching) were also present.
(J) Recurrent shouting (klazomania) in a patient with
functional disorder (previously published without video
material294). The patient first developed sudden jerks of
the head, neck, and left arm combined with involuntary
vocalizations such as screams, yelps, and grunts a few
days after a minor traffic accident at age 33. Sudden
movements and screams were not preceded by premoni-
tory urges, were not suppressible, and were triggered
by unexpected bright lights or taps, stress, and anger,
but also occurred spontaneously. Neurophysiological
analysis of startle-induced behaviors showed variable
patterns of muscle activation and prolonged activation
latencies. (K) Stuttering in a patient with Parkinson’s dis-
ease and deep brain stimulation (DBS) in DBS-OFF (K-
1) and DBS-ON (K-2) conditions. (L) Echolalia (“mit
mir,” ie, “with me”) in a patient with Niemann-Pick
type C. (M) Echolalia (“Christmas,” “ice cream,” “bug-
ger”) in a patient with a functional neurological disor-
der. She presented with jerks, which first started in her
right arm during a driving lesson 2 years earlier and then
spread over her whole body. During the same period,
she began to repeat words spoken by other people (echo-
lalia) and imitate other people’s actions (echopraxia).
Movements and vocalizations, although sometimes pre-
ceded by inner tension, could not completely be inhibited
voluntarily. However, they were distractible. Sudden
spontaneous jerking during walking was also docu-
mented (previously published295). (N) Repetitive contin-
uous swearing (“functional coprolalia”) in a patient with
functional neurological disorder and a previous diagno-
sis of TS. The repetitive swearing (“Hure”) occurred in
bouts and over prolonged periods and was context
dependent, that is, triggered only when the patient met
his previous partner or discussed her. During the same
period, he also developed a functional gait disorder,
which he described as the inability to walk as a result of
“extreme tension” that lasted for a period of 2 years and
resolved spontaneously.
Video 2. Vocalizations as part of stereotypies.
(A) Stereotypic vocalizations accompanied by motor ste-
reotypies (repetitive touching of the right ear) in a
patient with autism spectrum disorder, before (A-1), dur-
ing (A-2), and after (A-3) treatment with botulinum
toxin of the vocal cords. (B) Stereotypic shouts accompa-
nied by motor stereotypies (flexion-extension movement
of the upper extremity) in a patient with 15q13.3 micro-
deletion syndrome and cognitive disability, impulsivity,
short stature, cachexia, and mitral valve insufficiency.
The stereotypic behavior developed 4 years earlier dur-
ing a stressful period. The patient reported a soothing
character of the repetitive shouts and movements, which
reduced a feeling of inner distress. The behavior was dis-
tractible, although the patient felt that she was not able
to suppress the movements and vocalizations.
Video 3. Vocalizations as part of chorea, dystonia, and
other dyskinesias. (A) Lip smacking in a patient with
tardive dyskinesia. (B) Panting and gasping in a patient
with tardive dyskinesia due to chronic metoclopramide
intake. (C) Acute-onset hissing and shrieking in a patient
with generalized choreodystonia subsequent to
lenalidomide treatment for multiple myeloma.
Video 4. Continuous groaning, moaning, grunting, and
shrieking. (A) Repetitive shouting associated with emo-
tional discomfort in a patient with HD. (B) Continuous
howling in a patient with parkinsonism and dementia.
(C) Continuous groaning in a patient with PSP
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(previously published159). (D) Continuous shrieking in a
patient with acquired hepatocerebral degeneration during
an acute encephalopathic episode (D-1) and after treat-
ment (D-2). (E) Continuous grunting with distractibility
(E-1) in a patient with a functional neurological disorder.
The continuous vocalizing behavior, which was distract-
ible and entrainable, began abruptly 4 years ago and was
perceived as involuntary. It remitted during talking, eat-
ing, and drinking. (F) Continuous shrieking in a patient
with functional neurological disorder (previously publi-
shed without video material294). Repetitive inspiratory
shrieking associated with facial grimacing, eye closure,
and variable jerks of the head and upper extremities trig-
gered by unexpected, loud noises or also occurring spon-
taneously. These behaviors, which were not preceded by
premonitory urges and were not suppressible, appeared
1 year after a head injury as a result of a traffic accident.
Comorbid anxiety disorder with panic attacks and forget-
fulness were noted.
Video 5. Vocalizations resembling physiological
reflexes. (A) Air gasping and belching as a result of
functional aerophagia in a patient with functional neu-
rological disorder. She described suffering from anxiety
episodes, which led to aerophagic behaviors with subse-
quent gastric distention and belching. (B) Recurrent
hiccup-like sounds in a patient with functional neuro-
logical disorder. These appeared abruptly following an
episode of severe diarrhea after food poisoning. She
could voluntarily suppress the hiccup-like sounds by
bending over or pressing the arms against the abdomi-
nal wall, but otherwise felt that she had no control over
them. Hiccup-like vocalizations remitted during eating
and drinking.
Video 6. Other involuntary vocalizations. Exagger-
ated pseudo-startle response with shouting and hissing
in a patient with functional neurological disorder.
There was a variable pattern of muscle recruitment and
vocalizations throughout examination, following acous-
tic and light tactile stimuli over different body areas,
but also preceding those. An irregular and frequency-
variable tremor of both arms, which was distractible
and entrainable, was also noted. “Huffing and puffing”
and other effortful behaviors were documented during
neurological examination.
Acknowledgments: The authors thank Dr. Andreas Horn for his sup-
port in preparing the medical illustration.
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